A high frequency of diabetes mellitus (OR 3.7, CI 1.1–11.8, p = 0.029) as well as antidiabetic use (OR 13.0, CI 2.2–33.9, p = 0.002) were observed in patients who had high TREML4 mRNA levels, and these patients also presented more extensive atherosclerotic lesions (Table 3). The gene discussed is TREML4; the disease is diabetes mellitus.